Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReOpen1: OPN-375 in Chronic Rhinosinusitis
NCT03781804Phase 3Completed
- Sponsor
- OptiNose
- Start
- Nov 2018
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of fluticasone propionate in chronic rhinosinusitis (CRS), sponsored by OptiNose. Started Nov 2018; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03781804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781804.